Kinins IV pp 549-558 | Cite as

Kinins, Receptors, Antagonists

  • Domenico Regoli
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 198A)


  1. 1.

    Kinins are potent myotropic agents acting on a variety of smooth muscle preparations: isolated arteries, veins, intestines, tracheae, urinary bladders, uteri, etc. In these tissues, kinins activate at least two different receptor types, B1 and B2.

  2. 2.

    B1 and B2 receptors for kinins have been identified by measuring the order of potency of agonists and the affinities of specific and competitive antagonists. Results of pharmacological studies have been confirmed by several investigators using binding assays with labelled bradykinin (BK) or desArg9BK.

  3. 3.

    Antagonists for kinins active on B1 and B2 receptors have been identified. Anti-B1 antagonists are specific, competitive and fairly potent: anti-B2 antagonists have been identified among compounds primarily developed as anti-tachykinins: these compounds are non-specific, noncompetitive and rather weak. They however may provide interesting new pharmacological tools, active against both kinins and tachykinins, two groups of endogenous peptides involved in the inflammatory process.

  4. 4.

    The type (direct, indirect) and the site (endothelial cell, smooth muscle fiber, autonomic nerve endings) of action of kinins in isolated vessels have been investigated. The results of various studies indicate that kinins do not act on the sympathetic nerve terminals of isolated organs in contrast with other peptides. Kinins do not promote the release of histamine or of 5-hydroxy-tryptamine from isolated arteries and veins.

  5. 5.

    Kinins are equally active in the presence and absence of indomethacin (an inhibitor of cyclooxygenase) or of BW 755C (an inhibitor of lipoxygenase) in some organs, while the actions of kinins on other organs are reduced to a variable extent by these inhibitors. In general, B1 receptor systems do not depend on the ctivation of arachidonic acid, while B2 receptor systems do: activation of the arachidonic acid cascade may be a feature of B2 receptors.

  6. 6.

    Stimulant effects of kinins on arterial or venous vessels are independent on the endothelium, while the relaxant effect on the dog carotid artery occurs only in vessels with intact endothelium. The mechanism of action of kinins and tachykinins appears to be different from that of acetylcholine, since the peptides effects are not influenced by BW 755C and ETYA, two inhibitors of lipooxygenase that reduce significantly the effect of acetylcholine.



Rabbit Aorta Smooth Muscle Fiber Arachidonic Acid Cascade Sympathetic Nerve Terminal Compound Biological Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    H. O. Schild, Receptor classification with special reference to β-adrenergic receptors, in: “Drug Receptors,” H. P. Rang, ed., University Park Press (1973).Google Scholar
  2. 2.
    A. S. F. Ash and H. O. Schild, Receptors mediating some actions of histamine, Brit. J. Pharmacol., 27: 427–439 (1966).Google Scholar
  3. 3.
    D. Regoli, Receptors for angiotensin. A critical analysis, Can. J. Physiol. Pharmacol., 57: 129–139 (1979).PubMedCrossRefGoogle Scholar
  4. 4.
    D. Regoli, J. Barabe, and W. K. Park, Receptors for bradykinin in rabbit aortae, Can. J. Physiol. Pharmacol., 55: 855–867 (1977).PubMedCrossRefGoogle Scholar
  5. 5.
    J. Barabe, F. Marceau, B. Theriault, J.-N. Drouin, and D. Regoli, Cardiovascular actions of kinins in the rabbit, Can. J. Physiol. Pharmacol., 57: 78–91 (1979).PubMedCrossRefGoogle Scholar
  6. 6.
    R. Couture, P. Gaudreau, S. St-Pierre, and D. Regoli, The dog common carotid artery: A sensitive bioassay for studying vasodilator effects of substance P and of kinins, Can. J. Physiol. Pharmacol., 58: 1234–1244 (1980).PubMedCrossRefGoogle Scholar
  7. 7.
    J. Mizrahi, R. Couture, S. Caranikas, and D. Regoli, Pharmacological effects of peptides on tracheal smooth muscle, Pharmacology, 25: 39–50 (1982).PubMedCrossRefGoogle Scholar
  8. 8.
    W. K. Park, S. St-Pierre, J. Barabé, and D. REgoli, Synthesis of peptides by the solid-phase method. III. Bradykinin: Fragments and analogs, Can. J. Biochem., 56: 92–100 (1978).Google Scholar
  9. 9.
    S. St-Pierre, P. Gaudreau, J.-N. Drouin, D. Regoli, and S. Lemaire, Synthesis of peptides by the solid-phase method. IV. Des-Arg9-brady- kinin and analogs, Can. J. Biochem., 57: 1084–1089 (1979).Google Scholar
  10. 10.
    D. Regoli and J. Barabe, Pharmacology of bradykinin and related kinins, Pharmacol. Rev., 32: 1–46 (1980).Google Scholar
  11. 11.
    D. Regoli, E. Escher, and J. Mizrahi, Mini-Review. Substance P: Structure-activity studies and the development of antagonists, Pharmacology, 28:301–320 (1984).PubMedCrossRefGoogle Scholar
  12. 12.
    J. Mizrahi, S. Dion, P. D–Orleans-Juste, and D. Regoli, Bombesin: Activities on smooth muscle and antagonism, Eur. J. Pharmacol., (Submitted).Google Scholar
  13. 13.
    D. Regoli, Peptide receptors on autonomic effectors: How should they be classified?, in: “Trends in Autonomic Pharmacology. Vol. 2,” S. Kalsner, ed., Urban and Schwarzenberg, Munich (1981).Google Scholar
  14. 14.
    D. Regoli, Neurohumoral regulation of precapillary vessels. The kalli-krein-kinin system, J. Cardiovasc. Pharmacol., 6(Suppl. 2):S401–S413 (1984).PubMedCrossRefGoogle Scholar
  15. 15.
    A. Nasjletti and K. U. Malik, Relationships between the kallikrein-kinin and prostaglandin systems, Life Sci., 25:99–110 (1979).PubMedCrossRefGoogle Scholar
  16. 16.
    R. F. Furchgott, The requirement for endothelial cells in the relaxation of arteries by acetylcholine and some other vasodilators, TIPS, 3:173–175 (1981).Google Scholar
  17. 17.
    B. M. Altura and N. Chand, Bradykinin-induced relaxation of renal and pulmonary arteries is dependent upon intact endothelial cells, Brit. J. Pharmacol., 74:10–11 (1981).CrossRefGoogle Scholar
  18. 18.
    D. Regoli, J. Mizrahi, P. D’Orleans-Juste, and S. Caranikas, Effects of kinins on isolated blood vessels. Role of endothelium, Can. J. Physiol. Pharmacol., 60:1580–1583 (1982).PubMedCrossRefGoogle Scholar
  19. 19.
    R. H. Goldstein and M. Wall, Activation of protein formation and cell division by bradykinin and des-Arg9-bradykinin, J. Biol. Chem., 259:9263–9268 (1984).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Domenico Regoli
    • 1
  1. 1.Department of Physiology and Pharmacology, Medical SchoolUniversity of SherbrookeSherbrookeCanada

Personalised recommendations